Results 11 to 20 of about 23,251 (254)
USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival [PDF]
CLL cells rely on BCR‐mediated signalling for survival and proliferation in part through suppression of FOXO1. FOXO1 activity is regulated by a plethora of post‐translational modifications including phosphorylation and ubiquitination. We demonstrated that dual inhibition of BCR signalling and the deubiquitinase USP7 activates FOXO1, modulating its ...
Hassan N.B. Almuhanna +8 more
wiley +2 more sources
Appearances can be deceptive: acute myeloid leukaemia simulating chronic lymphocytic leukaemia [PDF]
To report a rare case of acute myeloid leukemia (AML) with abnormal chromatin clumping (ACC) in myeloblasts mimicking chronic lymphocytic leukemia (CLL), highlighting the associated diagnostic challenges.
Horsefield Beatriz Gómez +5 more
doaj +2 more sources
Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review [PDF]
Chronic lymphocytic leukaemia (CLL) is a chronic lymphoproliferative disease characterized by the proliferation of monoclonal B lymphocytes. It is the most common adult leukaemia in Western populations.
Krzysztof Michalak +4 more
doaj +2 more sources
Real-world disease characteristics and frontline treatments used in chronic lymphocytic leukaemia in Bulgaria: An observational cohort study (DESCRIBE) [PDF]
Objective Bruton tyrosine kinase inhibitors and B-cell lymphoma 2 inhibitors are currently the new standard active agents in chronic lymphocytic leukaemia. This observational study describes the real-world use of frontline treatment in Bulgarian patients
Vasko Graklanov +15 more
doaj +2 more sources
The immunodeficiency of chronic lymphocytic leukaemia [PDF]
Patients with chronic lymphocytic leukaemia (CLL) have progressive immunodeficiency and infection is the commonest cause of death. This review seeks to identify the extent of the abnormality, its cause, clinical significance and any possible remedy.TJH has studied CLL for the past 40 years and has scanned or read every paper he could find published on ...
A D, Hamblin, T J, Hamblin
openaire +2 more sources
Relapse of chronic lymphocytic leukaemia and non-Hodgkin's lymphoma after standard of care treatment is common and new therapies are needed. The targeted alpha therapy with 212Pb-NNV003 presented in this study combines cytotoxic α-particles from 212Pb ...
Astri Fjelde Maaland +6 more
doaj +1 more source
Objective: To determine the frequency of trisomy 12 in B-Cell chronic lymphocytic leukaemia (CLL), to correlate its association with clinico-pathologic features and to determine the role of this cytogenetic defect to the prognosis. Study Design: Cross
Ali Ahmed +5 more
doaj +1 more source
COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19).
Balraj Singh +5 more
doaj +1 more source
Chronic Lymphocytic Leukaemia [PDF]
AbstractAlthough chronic lymphocytic leukaemia (CLL) was one of the first two entities in which CAR-T cells were evaluated, it has not yet arrived in the clinical routine. Since the landmark study by Porter et al. (2011), only six CLL-specific clinical trials have been published, altogether comprising no more than 155 patients (Porter et al. 2015; Gill
Olivier Tournilhac, Peter Dreger
openaire +1 more source
Chronic lymphocytic leukaemia with concomitant plasmablastic lymphoma
Plasmablastic lymphomas are high-grade lymphomas that usually occur in immune-suppressed patients. Occasionally, they can arise from an underlying haematolymphoid malignancy, termed ‘transformed plasmablastic lymphoma’. In this report, we describe a case
Jacqueline Goedhals +2 more
doaj +1 more source

